These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 9525433)

  • 21. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.
    Van Damme L; Chandeying V; Ramjee G; Rees H; Sirivongrangson P; Laga M; Perriëns J
    AIDS; 2000 Jan; 14(1):85-8. PubMed ID: 10714571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers.
    Weir SS; Roddy RE; Zekeng L; Feldblum PJ
    Genitourin Med; 1995 Apr; 71(2):78-81. PubMed ID: 7744418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colposcopy: still useful in microbicide safety trials?
    Mauck CK; Weiner DH; Lai JJ; Schwartz JL
    Sex Transm Dis; 2012 Jun; 39(6):465-9. PubMed ID: 22592833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial.
    Richardson BA; Lavreys L; Martin HL; Stevens CE; Ngugi E; Mandaliya K; Bwayo J; Ndinya-Achola J; Kreiss JK
    Sex Transm Dis; 2001 Jul; 28(7):394-400. PubMed ID: 11460023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of spermicide containing nonoxynol-9 in the prevention of HIV infection.
    Bird KD
    AIDS; 1991 Jul; 5(7):791-6. PubMed ID: 1654056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections.
    Niruthisard S; Roddy RE; Chutivongse S
    Lancet; 1992 Jun; 339(8806):1371-5. PubMed ID: 1350804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
    Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate.
    Psychoyos A; Creatsas G; Hassan E; Georgoulias V; Gravanis A
    Hum Reprod; 1993 Jun; 8(6):866-9. PubMed ID: 7688380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9.
    Mauck CK; Allen S; Baker JM; Barr SP; Abercrombie T; Archer DF
    Contraception; 1997 Aug; 56(2):103-10. PubMed ID: 9315419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.
    Mauck CK; Weiner DH; Ballagh SA; Creinin MD; Archer DF; Schwartz JL; Pymar HC; Lai JJ; Rencher WF; Callahan MM;
    Contraception; 2004 Jul; 70(1):77-83. PubMed ID: 15208057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-9 contraceptive film and the risk of STDs.
    Netw Res Triangle Park N C; 1997; 17(3):5-7. PubMed ID: 12292395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women.
    Van Damme L; Wright A; Depraetere K; Rosenstein I; Vandersmissen V; Poulter L; McKinlay M; Van Dyck E; Weber J; Profy A; Laga M; Kitchen V
    Sex Transm Infect; 2000 Apr; 76(2):126-30. PubMed ID: 10858715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and tolerability of the new contraceptive sponge Protectaid.
    Creatsas G; Elsheikh A; Colin P
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):91-5. PubMed ID: 12201327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity.
    D'Cruz OJ; Zhu Z; Yiv SH; Chen CL; Waurzyniak B; Uckun FM
    Contraception; 1999 May; 59(5):319-31. PubMed ID: 10494486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of single daily use for one week of C31G HEC gel in women.
    Ballagh SA; Baker JM; Henry DM; Archer DF
    Contraception; 2002 Nov; 66(5):369-75. PubMed ID: 12443969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.
    Kreiss J; Ngugi E; Holmes K; Ndinya-Achola J; Waiyaki P; Roberts PL; Ruminjo I; Sajabi R; Kimata J; Fleming TR
    JAMA; 1992 Jul 22-29; 268(4):477-82. PubMed ID: 1320133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of three nonoxynol-9 preparations on vaginal flora and epithelium.
    Watts DH; Rabe L; Krohn MA; Aura J; Hillier SL
    J Infect Dis; 1999 Aug; 180(2):426-37. PubMed ID: 10395859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of nonoxynol-9-containing spermicides on urogenital infection.
    McGroarty JA; Reid G; Bruce AW
    J Urol; 1994 Sep; 152(3):831-3. PubMed ID: 8051730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Condoms and urinary tract infections: is nonoxynol-9 the problem or the solution?
    Steiner MJ; Cates W
    Epidemiology; 1997 Nov; 8(6):612-4. PubMed ID: 9345658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased COX-2 expression in human vaginal epithelial cells exposed to nonoxynol-9, a vaginal contraceptive microbicide that failed to protect women from HIV-1 infection.
    Zalenskaya IA; Cerocchi OG; Joseph T; Donaghay MA; Schriver SD; Doncel GF
    Am J Reprod Immunol; 2011 Jun; 65(6):569-77. PubMed ID: 21241401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.